Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012)
Opko Health's (OPK) quarterly Preferred Stock Liabilities came in at $24.4 million in Q4 2012, little changed YoY from $24.4 million in Q1 2012, and little changed on a QoQ basis from $24.4 million in Q3 2012.
Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012) Analysis & Trends
Opko Health (OPK) has 2 years of Preferred Stock Liabilities data on file, last reported at $24.4 million in Q4 2012.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $24.4 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $24.4 million (changed 0.0% YoY) and the FY2012 annual result came in at $24.4 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities held at $24.4 million in Q4 2012, from $24.4 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $24.4 million in Q4 2011 to a low of $24.4 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | - |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | Opko Health | 1.01 Bn | 712.28 Mn | 80.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 24.39 Mn |
| Sep 30, 2012 | 24.39 Mn |
| Jun 30, 2012 | 24.39 Mn |
| Dec 31, 2011 | 24.39 Mn |